Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Study of Lanreotide to Treat Polycystic Kidney Disease (DIPAK1)

This study is currently recruiting participants. (see Contacts and Locations)
Verified January 2014 by University Medical Centre Groningen
Sponsor:
Collaborators:
Leiden University Medical Center
Erasmus Medical Center
Radboud University
Information provided by (Responsible Party):
dr. R.T. Gansevoort, University Medical Centre Groningen
ClinicalTrials.gov Identifier:
NCT01616927
First received: June 6, 2012
Last updated: January 20, 2014
Last verified: January 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: June 2017
  Estimated Primary Completion Date: January 2017 (Final data collection date for primary outcome measure)